GlassScriptPhysician profile
Heba El Goweni
NPI 1003842121
$389.21
in general payments reported to CMS, 2019-2025
7 companies · $56.72 in 2025
The $56.72 reported for 2025 was less than what a typical Adolescent Medicine (Pediatrics) provider received nationally (typical 2025 total: $99.31).
See the full distribution for Adolescent Medicine (Pediatrics)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $210 · 2020: $31.83 · 2022: $13.73 · 2023: $56.21 · 2024: $20.65 · 2025: $56.72.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $134.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $133.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $115.00 | 2019-2025 | Bexsero |
| Phadia US INC. | $103.02 | 2019 | |
| Tris Pharma INC | $54.60 | 2019 | |
| Merck Sharp & Dohme LLC | $42.49 | 2019-2025 | Gardasil 9, Rotateq, Vaxneuvance |
| Sanofi Pasteur INC. | $33.67 | 2019-2020 | |
| Corium, LLC | $28.59 | 2025 | Azstarys |
| Pfizer INC. | $11.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heba El Goweni listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.